Скачать или смотреть Reshoring pharmaceutical and life science manufacturing to the U.S - vertical

Why reshoring pharmaceutical and life science manufacturing to the U.S. makes business sense

In today's rapidly evolving global landscape, the pharmaceutical and life sciences industries face unprecedented challenges. Regardless of your personal political viewpoint, recent policy shifts, including new tariffs and quotas on critical materials are threatening to disrupt traditional supply chains, leading to increased costs and unpredictability.

Import restrictions and customs delays will likely create bottlenecks, making foreign sourcing less viable. Life science and pharmaceutical companies will grapple with higher costs and longer lead times, impacting their ability to meet market demands.

To mitigate these risks, many are turning to reshoring—bringing manufacturing back to the United States. This strategic move not only enhances supply chain resilience but also offers greater control over production processes. As an example, Eli Lilly has announced an additional $27B capital expansion in the US to create four new manufacturing sites.

As an alternative, partnering with a U.S.-based CMO, such as Argonaut Manufacturing Services, provides a rapidly deployable reshoring solution without the need for additional infrastructure. This approach helps organizations quickly step-up to US domestic manufacturing  in a site that is already FDA inspected.

When presenting the case for reshoring to stakeholders, consider these factors: the financial resilience reshoring offers against global disruptions, long-term cost benefits from stabilized logistics and potential tax incentives, and the competitive advantage of being recognized for quality assurance and supply reliability.

Life science and pharmaceutical companies will grapple with higher cost and longer lead times impacting their ability to meet market demands.

Partner with Argonaut Manufacturing Services to future-proof your supply chain with an experienced team.

For more information, visit argonautms.com to learn more.